 | Up a level |
Pennell, D. and Porter, J.B. and Cappellini, M.D. and Chan, L.L. and El-Beshlawy, A. and Aydinok, Y. and Ibrahim, H. and Li, Chi-Kong and Viprakasit, V. and Elalfy, M.S. and Kattamis, A. and Smith, G. and Habr, D. and Domokos, G. and Roubert, B. and Taher, A. (2010) Continued improvement and normalization of myocardial T2*in patients with beta-thalassemia major treated with deferasirox (Exjade (R)) for up to 3 years. Blood, 116 (21). pp. 1735-1736.
